147 related articles for article (PubMed ID: 2573682)
21. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells.
Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW; Kipp JB
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):489-96. PubMed ID: 9308955
[TBL] [Abstract][Full Text] [Related]
22. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
[TBL] [Abstract][Full Text] [Related]
23. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
Rodriguez R; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
[No Abstract] [Full Text] [Related]
24. Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
Epstein AH; Lebovics RS; Van Waes C; Smith J; Okunieff P; Cook JA
Laryngoscope; 1998 Jul; 108(7):1090-4. PubMed ID: 9665262
[TBL] [Abstract][Full Text] [Related]
25. Radiation enhancement with iodinated deoxyuridine.
Fairchild RG; Brill AB; Ettinger KV
Invest Radiol; 1982; 17(4):407-16. PubMed ID: 6813285
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy.
Miller RW; DeGraff W; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1193-7. PubMed ID: 3610707
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
Kinsella TJ
Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
[TBL] [Abstract][Full Text] [Related]
28. Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine.
Miller EM; Fowler JF; Kinsella TJ
Radiat Res; 1992 Jul; 131(1):81-9. PubMed ID: 1626052
[TBL] [Abstract][Full Text] [Related]
29. Continuous infusion of halogenated pyrimidines.
Rodriguez R; Miller E; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1380-2. PubMed ID: 2045313
[No Abstract] [Full Text] [Related]
30. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Boothman DA; Greer S; Pardee AB
Cancer Res; 1987 Oct; 47(20):5361-6. PubMed ID: 3652040
[TBL] [Abstract][Full Text] [Related]
31. The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.
McGinn CJ; Kinsella TJ
Semin Oncol; 1992 Aug; 19(4 Suppl 11):21-8. PubMed ID: 1509278
[TBL] [Abstract][Full Text] [Related]
32. Keynote address: hypoxic cell radiosensitizers: where next?
Brown JM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):987-93. PubMed ID: 2649468
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
34. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
Lokshina AM; Pelevina II
Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
[No Abstract] [Full Text] [Related]
35. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of radiation sensitizing agents.
Goffinet DR; Bagshaw MA
Cancer Treat Rev; 1974 Mar; 1(1):15-26. PubMed ID: 4143475
[No Abstract] [Full Text] [Related]
37. Radiopharmaceuticals (Strontium 89) and radiosensitizers (idoxuridine).
Otto SE
J Intraven Nurs; 1998; 21(6):335-7. PubMed ID: 10392098
[TBL] [Abstract][Full Text] [Related]
38. Ataxia telangiectasia cells exhibit the same radiosensitization response by incorporation of BrdUrd or IdUrd as do normal human cells.
Raaphorst GP; Azzam EI; Vadasz JA
Radiat Res; 1985 Sep; 103(3):455-60. PubMed ID: 4034938
[TBL] [Abstract][Full Text] [Related]
39. Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1992; 22(3):499-503. PubMed ID: 1735687
[TBL] [Abstract][Full Text] [Related]
40. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
Onoyama Y; Nakajima T; Tanaka M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]